GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AREV Life Sciences Global Corp (OTCPK:AREVF) » Definitions » Net Margin %

AREV Life Sciences Global (AREV Life Sciences Global) Net Margin % : 0.00% (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is AREV Life Sciences Global Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. AREV Life Sciences Global's Net Income for the three months ended in Sep. 2023 was $-0.02 Mil. AREV Life Sciences Global's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, AREV Life Sciences Global's net margin for the quarter that ended in Sep. 2023 was 0.00%.

The historical rank and industry rank for AREV Life Sciences Global's Net Margin % or its related term are showing as below:

AREVF' s Net Margin % Range Over the Past 10 Years
Min: -3414.29   Med: -1093.33   Max: -388.24
Current: -3414.29


AREVF's Net Margin % is ranked worse than
97.36% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.06 vs AREVF: -3414.29

AREV Life Sciences Global Net Margin % Historical Data

The historical data trend for AREV Life Sciences Global's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AREV Life Sciences Global Net Margin % Chart

AREV Life Sciences Global Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -1,638.51 -549.66 -388.44 -2,952.78

AREV Life Sciences Global Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,064.71 1,180.00 - - -

Competitive Comparison of AREV Life Sciences Global's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, AREV Life Sciences Global's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AREV Life Sciences Global's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AREV Life Sciences Global's Net Margin % distribution charts can be found below:

* The bar in red indicates where AREV Life Sciences Global's Net Margin % falls into.



AREV Life Sciences Global Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

AREV Life Sciences Global's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-1.063/0.036
=-2,952.78 %

AREV Life Sciences Global's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin=Net Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-0.021/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AREV Life Sciences Global  (OTCPK:AREVF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


AREV Life Sciences Global Net Margin % Related Terms

Thank you for viewing the detailed overview of AREV Life Sciences Global's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


AREV Life Sciences Global (AREV Life Sciences Global) Business Description

Traded in Other Exchanges
N/A
Address
91 Golden Drive, Unit 18, Coquitlam, BC, CAN, V3K 6R2
AREV Life Sciences Global Corp is a fully integrated, early stage life science discovery enterprise dedicated to delivering solutions to public healthcare metrics through innovations and successful collaborations in the life science industry. The Company's focuses on dedication to generate revenue by way of novel therapeutic approaches to human nutrition and malnutrition, pandemic diseases, and neglected chronic co-morbidities.

AREV Life Sciences Global (AREV Life Sciences Global) Headlines